CS logo
small CS logo
St. Elisabethen Krankenhaus

Frankfurt Am Main, Germany
Allgemeinkrankenhaus, Frankfurt am Main, Hessen

About St. Elisabethen Krankenhaus


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at St. Elisabethen Krankenhaus


During the past decade, St. Elisabethen Krankenhaus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "St. Elisabethen Krankenhaus" #1 collaborator was "PneumRx, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at St. Elisabethen Krankenhaus


According to Clinical.Site data, the most researched conditions in "St. Elisabethen Krankenhaus" are "Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Emphysema" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "St. Elisabethen Krankenhaus" in a lesser frequency.

Clinical Trials Intervention Types at St. Elisabethen Krankenhaus


Most popular intervention types in "St. Elisabethen Krankenhaus" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Atezolizumab" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials). Other intervention names were less common.

Clinical Trials Genders at St. Elisabethen Krankenhaus


The vast majority of trials in "St. Elisabethen Krankenhaus" are 6 trials for "All" genders.

Clinical Trials Status at St. Elisabethen Krankenhaus


Currently, there are NaN active trials in "St. Elisabethen Krankenhaus". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in St. Elisabethen Krankenhaus, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in St. Elisabethen Krankenhaus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".